Elevated Triglyceride-Glucose (TyG) Index Predicts Poor Clinical Outcomes in Critically Ill AECOPD Patients: A Retrospective Study
International Journal of Chronic Obstructive Pulmonary Disease · 2024
DOI: 10.2147/copd.s477268 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2024. Verfasst von Xin Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Deyang People's Hospital, Deyang, Sichuan, 618099, People's Republic of China. Hauptthemen laut MEDLINE: Critical Illness, Hospital Mortality, Triglycerides, Biomarkers. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
The triglyceride-glucose (TyG) index is a surrogate biomarker of insulin resistance which has been widely used in intensive care unit (ICU) to predict prognosis. However, its role in critically ill acute exacerbation of COPD (AECOPD) patients remains largely unknown. Material and methods: A total of 645 AECOPD patients were induced in this retrospective cohort study, which extracted data from the eICU Collaborative Research Database (eICU-CRD). The TyG index was calculated as Ln (fasting triglycerides (mg/dL) × fasting plasma glucose (mg/dL)/2). The primary endpoint includes in-hospital mortality and ICU mortality. The secondary endpoint was sepsis, acute kidney injury (AKI), and acute respiratory failure (ARF).
Results
Multivariable Cox regression analysis revealed that the TyG index was independently associated with an increased risk of in-hospital mortality (hazard ratio, HR: 1.45, 95% CI: 1.04-2.01, P = 0.028) and ICU mortality (HR: 2.13, 95% CI: 1.28-3.54, P = 0.004). Moreover, the TyG index was independently associated with an increased risk of sepsis (odds ratio, OR: 1.54, 95% CI: 1.24-1.93, P < 0.001), AKI (OR: 1.57, 95% CI: 1.26-2.02, P < 0.001) and ARF (OR: 1.50, 95% CI: 1.20-1.87, P < 0.001). Kaplan-Meier survival analysis revealed that higher TyG indexes were also related to increased in-hospital mortality and ICU mortality. In addition, the restricted cubic splines regression model demonstrated that the in-hospital mortality and ICU mortality increased linearly with increasing TyG index (P for non-linearity = 0.897, P for non-linearity = 0.897, respectively).
Conclusion
Elevated TyG index was independently associated with an increased risk of poor clinical outcomes in critically ill AECOPD patients. A prospective study to define TyG as a biomarker for prognosis prediction in critically ill AECOPD patients is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Deyang People's Hospital, Deyang, Sichuan, 618099, People's Republic of China.
- Department of Respiratory Medicine, People's Hospital of Shizhu Tujia Autonomous County, Chongqing, 409199, People's Republic of China.
- Department of Cardiology, 63650 Military Hospital, Urumqi, Xinjiang, 841700, People's Republic of China.
- Precision Medicine Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China.
Zitieren
APA
Wang, X., Cui, X., Fan, H., & Hu, T. (2024). Elevated Triglyceride-Glucose (TyG) Index Predicts Poor Clinical Outcomes in Critically Ill AECOPD Patients: A Retrospective Study. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s477268
Vancouver
Wang X, Cui X, Fan H, Hu T. Elevated Triglyceride-Glucose (TyG) Index Predicts Poor Clinical Outcomes in Critically Ill AECOPD Patients: A Retrospective Study. International Journal of Chronic Obstructive Pulmonary Disease. 2024. doi:10.2147/copd.s477268
BibTeX
@article{Wang2024,
author = {Wang, Xin and Cui, Xuerong and Fan, Huaping and Hu, Tianyang},
title = {Elevated Triglyceride-Glucose (TyG) Index Predicts Poor Clinical Outcomes in Critically Ill AECOPD Patients: A Retrospective Study},
journal = {International Journal of Chronic Obstructive Pulmonary Disease},
year = {2024},
doi = {10.2147/copd.s477268}
}
EUVIMED